Eli Lilly to buy Versanis for up to $1.93 billion in obesity drugs push
(Reuters) -Eli Lilly and Co said on Friday it will buy privately held Versanis for potentially up to $1.93 billion to strengthen its position in the fast-growing market for weight-loss treatments.